Untitled

Download a copy of this content.

Supporting Documents & Procedures Checklists

Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand.

HealthTrust presents…“Hypertensive Disorders of Pregnancy” (Part 2 Update in the Maternal Morbidity & Mortality series)

Despite a worldwide trend toward improvement in maternal morbidity and mortality, rates in the U.S. have surged in recent years. Specifically, the unacceptable rates of preventable adverse events in childbirth are topping 50 percent. A major reason for this tragic result is poor recognition and appropriate treatment of hypertensive disorders during pregnancy. This program will review the four major hypertensive disorders of obstetrics and focus on the rapid diagnosis and treatment of hypertensive emergencies—a major cause of maternal deaths. A tailored, multi-disciplinary approach including contributions from pharmacists, nurses and lab clinicians is essential for successful outcomes in the treatment of hypertensive disorders.

Learning Objectives  |  At the end of this session, participants should be able to:

1. Describe the four types of hypertension that can complicate pregnancy
2. Discuss maternal and fetal complications that can result from hypertensive disorders of pregnancy
3. Outline treatment strategies for the management of hypertensive emergencies in pregnancy
4. Identify the benefits of utilizing an evidence-based care team approach to aid patients with hypertensive disorders

Presenter:

Frank R. Kolucki, Jr., M.D.  FACOG  |  Chairman of the Department of Obstetrics & Gynecology  |  Moses Taylor Hospital

Target Audience: Physicians, Nurses, Pharmacists & Lab

Continuing Education Information: 1.0 contact hours approved for Nurses, Pharmacists and Lab professionals. Belmont University College of Pharmacy  is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0863-9999-20-077-L04-P. Pfiedler is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. The activity is approved for 1 hour of continuing education credit to pharmacists, nurses and lab professionals who attend the webinar and complete the online evaluation. California Board of Registered Nursing Approval. Pfiedler is a provider approved by the California Board of Registered Nursing, Provider Number CEP 14944 for 1.0 contact hour.

Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.

Search the calendar for previous topics in the updated Maternal Morbidity & Mortality Series:

• August 19, 2020 – Code Crimson: Massive Transfusion Protocol

Effective June 1, 2019: Belmont College of Pharmacy will no longer issue paper/electronic statements of credit for CE activities. ACPE (our accrediting body) policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor at www.nabp.net.  A participant, sponsor, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at david.gregory@belmont.edu. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.